MetaMed Briefings

Infection prevention, written by clinicians.

Evidence-led briefings on AMR, surveillance, outbreaks and stewardship — for IPC leads, microbiologists and hospital epidemiologists.

FeaturedAMR21 April 2026

Paediatric multidrug-resistant infections in the UK, 2023 to 2026

England's latest paediatric bacteraemia surveillance shows rising bloodstream infection incidence through 2023, with neonates carrying the heaviest burden and resistant Gram-negatives still defining the main IPC risk. The signal since 2023 is not a single paediatric superbug surge, but a persistent mix of neonatal Gram-negative disease, sporadic MRSA, and widening concern about carbapenem-resistant Enterobacterales in healthcare and community networks.

Read briefing

Surveillance21 Apr 2026

UKHSA's latest CPE data show pressure rising in NHS hospitals

England's mandatory surveillance shows carbapenemase-producing organisms are still climbing, driven mainly by screening detections rather than invasive disease. For IPC teams, the signal is clear: regional spread is broadening, NDM remains ascendant, and hospital-network control matters more than single-site responses.